NASDAQ: GNPX
Genprex Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their GNPX stock forecasts and price targets.

Forecast return on equity

Is GNPX forecast to generate an efficient return?

Company
N/A
Industry
1,575.97%
Market
76.96%

Forecast return on assets

Is GNPX forecast to generate an efficient return on assets?

Company
N/A
Industry
1,136.33%

GNPX earnings per share forecast

What is GNPX's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.71

GNPX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
GNPX$0.23N/AN/A
ADXN$6.75N/AN/A
BCLI$0.86N/AN/A
LYRA$0.09$2.00+2,198.85%Hold
SPRB$0.12$1.75+1,346.28%Hold

Genprex Stock Forecast FAQ

What is GNPX's earnings growth forecast for 2025-2025?

(NASDAQ: GNPX) Genprex's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 46.04%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 71.14%.

Genprex's earnings in 2025 is -$21,388,282.

In 2025, GNPX is forecast to generate -$65,454,218 in earnings, with the lowest earnings forecast at -$65,454,218 and the highest earnings forecast at -$65,454,218.

If you're new to stock investing, here's how to buy Genprex stock.

What is GNPX's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: GNPX) forecast ROE is N/A, which is considered weak.

What is GNPX's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: GNPX) Genprex's current Earnings Per Share (EPS) is -$5.34. In 2025, GNPX's EPS is forecast to hit -$2.71 (min: -$2.71, max: -$2.71).

What is GNPX's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: GNPX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 1,136.33%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.